Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
M. Samir Arnaout, Wael Almahmeed, Mohsen Ibrahim, James Ker, Ma Taher Khalil, Corrie T. Van Wyk, Giuseppe Mancia & Eyas Al Mousa. (2011) Hypertension and its management in countries in Africa and the Middle East, with special reference to the place of -blockade. Current Medical Research and Opinion 27:6, pages 1223-1236.
Read now
Read now
B. Tomlinson, J.J. Dalal, J. Huang, L.P. Low, C.G. Park, A.R. Rahman, E.B. Reyes, A.A. Soenarta, A. Heagerty & F. Follath. (2011) The role of -blockers in the management of hypertension: An Asian perspective. Current Medical Research and Opinion 27:5, pages 1021-1033.
Read now
Read now
Subhashis Chakraborty, Dali Shukla, Brahmeshwar Mishra & Sanjay Singh. (2010) Clinical updates on carvedilol: a first choice β-blocker in the treatment of cardiovascular diseases. Expert Opinion on Drug Metabolism & Toxicology 6:2, pages 237-250.
Read now
Read now
Ahmed I El-Sakka, Rany Shamloul & Aksam A Yassin. (2009) Erectile dysfunction, cardiovascular diseases and depression: interaction of therapy. Expert Opinion on Pharmacotherapy 10:13, pages 2107-2117.
Read now
Read now
Articles from other publishers (5)
Brent Egan, John Flack, Mehul Patel & Sofia Lombera. (2018) Insights on β-blockers for the treatment of hypertension: A survey of health care practitioners. The Journal of Clinical Hypertension 20:10, pages 1464-1472.
Crossref
Crossref
Stefania Marazia, Lucia Urso, Marco Contini, Marco Pano, Salvatore Zaccaria, Vincenzo Lenti, Filippo M. Sarullo & Michele Di Mauro. (2015) The Role of Ivabradine in Cardiac Rehabilitation in Patients With Recent Coronary Artery Bypass Graft. Journal of Cardiovascular Pharmacology and Therapeutics 20:6, pages 547-553.
Crossref
Crossref
Joel M. Neutel, Thomas D. Giles, Henry Punzi, Robert J. Weiss, Huiling Li & Amy Finck. (2014) Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study. Journal of the American Society of Hypertension 8:12, pages 915-920.
Crossref
Crossref
Thomas D Giles, Michael A Weber, Jan Basile, Alan H Gradman, David B Bharucha, Wei Chen & Manoj Pattathil. (2014) Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study. The Lancet 383:9932, pages 1889-1898.
Crossref
Crossref
Jillian G. Baker, Philip Kemp, Julie March, Laurice Fretwell, Stephen J. Hill & Sheila M. Gardiner. (2011)
Predicting
in vivo
cardiovascular properties of β‐blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses
. The FASEB Journal 25:12, pages 4486-4497.
Crossref
Crossref